scispace - formally typeset
L

Li Chu

Researcher at Hebei Medical University

Publications -  28
Citations -  545

Li Chu is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Medicine & Oxidative stress. The author has an hindex of 14, co-authored 16 publications receiving 424 citations.

Papers
More filters
Journal ArticleDOI

Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats

TL;DR: It is found that paeoniflorin has therapeutic potential against NAFLD and that it acts through multiple signaling pathways, including regulating lipid metabolism and exerting insulin sensitizing effect by regulating the insulin signaling pathway IRS/Akt/GSK3β and anti-oxidation.
Journal ArticleDOI

Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.

TL;DR: Long-term treatment with fasudil could improve cardiac dysfunction, attenuate myocardial injury and prevent pathological changes in a rat model of diabetic cardiomyopathy, and these effects could be attributed to regulation of antioxidative activities, suppression of my cardiac hypertrophy, apoptosis, fibrosis and subsequent cardiac remodeling.
Journal ArticleDOI

Nephroprotective effect of calcium channel blockers against toxicity of lead exposure in mice.

TL;DR: Both verapamil and nimodipine showed protection against Pb-induced kidney injury, including alleviation of renal pathological damage and decreasing the level of Pb in kidney homogenate and extent of apoptosis in nephrocytes, which implicate the therapeutic potential of CCBs for P b-induced nephrotoxicity.
Journal ArticleDOI

Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway.

TL;DR: PF has liver protective and anti-inflammatory effects in HCF diet-induced NASH rats and the possible mechanisms may be associated with inhibition of the ROCK/NF-κB signaling pathway in the NASH liver.
Journal ArticleDOI

Multitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza.

TL;DR: Treatment of chronic iron-overloaded mice with SM dose-dependently ameliorated changes in hepatic morphology and coefficient, and displayed anti-fibrotic activity in the liver induced by chronic iron overload, which may be attributed to multitargeted inhibition of iron deposition and collagen accumulation, as well as oxidative stress, inflammation and apoptosis.